KFFB:NASDAQKentucky First Federal Bancorp Analysis
Data as of 2026-04-12 - not real-time
$4.41
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
KFFB trades at a premium relative to its peers with a price multiple far above the industry average, suggesting the stock may be stretched despite solid operating margins. Technical signals are mixed: the price sits near short‑term support, the RSI hovers around the midpoint, and a modest bullish MACD histogram hints at limited upside, while decreasing volume and elevated 30‑day volatility signal caution.
Fundamentally, the bank shows encouraging revenue growth and a healthy operating margin, yet a low return on equity, modest cash position versus debt, and zero dividend payout limit defensive appeal. The near‑zero beta indicates minimal market‑wide price sensitivity, but the small market cap and thin trading volume raise liquidity concerns. Overall, the stock appears overvalued on earnings metrics, balanced by a relatively low price‑to‑book ratio and regional growth opportunities.
Fundamentally, the bank shows encouraging revenue growth and a healthy operating margin, yet a low return on equity, modest cash position versus debt, and zero dividend payout limit defensive appeal. The near‑zero beta indicates minimal market‑wide price sensitivity, but the small market cap and thin trading volume raise liquidity concerns. Overall, the stock appears overvalued on earnings metrics, balanced by a relatively low price‑to‑book ratio and regional growth opportunities.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 6/10
Key Factors
- price near support with high short‑term volatility
- overvalued earnings multiple
- decreasing trading volume
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- strong revenue growth trajectory
- moderate operating profitability
- valuation gap between price‑to‑earnings and price‑to‑book
Long Term
> 3 yearsPositive
Model confidence: 6/10
Key Factors
- low price‑to‑book suggests upside potential
- regional market focus with growth opportunities
- stable beta indicating limited market‑wide risk
Key Metrics & Analysis
Financial Health
Revenue Growth27.80%
Profit Margin8.24%
P/E Ratio44.1
ROE1.71%
ROA0.22%
P/B Ratio0.7
Op. Cash Flow$21.0K
Industry P/E17.1
Technical Analysis
TrendNeutral
RSI48.3
Support$4.18
Resistance$4.85
MA 20$4.41
MA 50$4.59
MA 200$3.97
MACDBullish
VolumeDecreasing
Fear & Greed Index87.09
Valuation
GradeOvervalued
TypeBlend
Risk Assessment
Beta-0.04
Volatility53.20%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.